Annual Operating Expenses
$13.30 M
-$250.00 K-1.84%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual total operating expenses is $13.30 million, with the most recent change of -$250.00 thousand (-1.84%) on December 1, 2023.
- During the last 3 years, NRSN annual operating expenses has risen by +$10.41 million (+360.60%).
- NRSN annual operating expenses is now -1.84% below its all-time high of $13.55 million, reached on December 31, 2022.
Performance
NRSN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.11 M
-$923.00 K-30.46%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly total operating expenses is $2.11 million, with the most recent change of -$923.00 thousand (-30.46%) on September 1, 2024.
- Over the past year, NRSN quarterly operating expenses has dropped by -$887.00 thousand (-29.63%).
- NRSN quarterly operating expenses is now -51.17% below its all-time high of $4.32 million, reached on December 1, 2023.
Performance
NRSN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NRSN Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.8% | -29.6% |
3 y3 years | +360.6% | -41.3% |
5 y5 years | +977.1% | -0.2% |
NRSN Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -1.8% | +138.1% | -51.2% | +28.1% |
5 y | 5-year | -1.8% | +977.1% | -51.2% | +139.4% |
alltime | all time | -1.8% | +977.1% | -51.2% | +139.4% |
NeuroSense Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.11 M(-30.5%) |
Jun 2024 | - | $3.03 M(+1.2%) |
Mar 2024 | - | $2.99 M(-30.6%) |
Dec 2023 | $13.30 M(-1.8%) | $4.32 M(+64.3%) |
Sep 2023 | - | $2.63 M(-22.1%) |
Jun 2023 | - | $3.37 M(+12.7%) |
Mar 2023 | - | $2.99 M(-11.5%) |
Dec 2022 | $13.55 M | $3.38 M(+1.8%) |
Sep 2022 | - | $3.32 M(-7.5%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $3.59 M(+10.0%) |
Mar 2022 | - | $3.26 M(+98.4%) |
Dec 2021 | $5.59 M(+93.5%) | - |
Dec 2021 | - | $1.65 M(+86.9%) |
Sep 2021 | - | $880.00 K(-7.5%) |
Jun 2021 | - | $951.00 K(-55.0%) |
Mar 2021 | - | $2.11 M |
Dec 2020 | $2.89 M(+133.8%) | - |
Dec 2019 | $1.24 M | - |
FAQ
- What is NeuroSense Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual operating expenses year-on-year change?
- What is NeuroSense Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly operating expenses year-on-year change?
What is NeuroSense Therapeutics annual total operating expenses?
The current annual operating expenses of NRSN is $13.30 M
What is the all time high annual operating expenses for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual total operating expenses is $13.55 M
What is NeuroSense Therapeutics annual operating expenses year-on-year change?
Over the past year, NRSN annual total operating expenses has changed by -$250.00 K (-1.84%)
What is NeuroSense Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of NRSN is $2.11 M
What is the all time high quarterly operating expenses for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly total operating expenses is $4.32 M
What is NeuroSense Therapeutics quarterly operating expenses year-on-year change?
Over the past year, NRSN quarterly total operating expenses has changed by -$887.00 K (-29.63%)